Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
Clinical trial NCT00020462 · COMPLETED
Trial details
- NCT number
- NCT00020462
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.